As the need for COVID-19 vaccinations dissipates, a raft of other vaccines is now on the table with more to come for pharmacy. But as many board the vaccine train to expand clinical services – and keep the money rolling in – questions are raised about whether the vaccine free-for-all is the answer to revenue woes. Paulette Crowley and Jonathan Chilton-Towle report